Filing Details
- Accession Number:
- 0001714899-22-000101
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-06-28 15:07:44
- Reporting Period:
- 2022-03-23
- Accepted Time:
- 2022-06-28 15:07:44
- Original Submission Date:
- 2022-03-25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1714899 | Denali Therapeutics Inc. | DNLI | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1437435 | Marc Tessier-Lavigne | C/O Denali Therapeutics Inc. 161 Oyster Point Blvd. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-03-23 | 8,402 | $33.40 | 2,035,968 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-03-23 | 11,598 | $34.14 | 2,024,370 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 78,848 | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 1 |
| Common Stock | 79,173 | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 2 |
| Common Stock | 78,848 | Indirect | The Tessier-Lavigne/Hynes Irrevocable Trust 3 |
Footnotes
- For this amended Form 4 filing the only change is to add the signature.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $32.76 to $33.75 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- Includes 2,074 restricted stock units.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.76 to $34.69 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee.
- The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee.
- The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee.
Billionaire Hedge Funds
